163 related articles for article (PubMed ID: 22197611)
1. Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase.
Petzer A; Harvey BH; Wegener G; Petzer JP
Toxicol Appl Pharmacol; 2012 Feb; 258(3):403-9. PubMed ID: 22197611
[TBL] [Abstract][Full Text] [Related]
2. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.
Petzer A; Harvey BH; Petzer JP
Toxicol Appl Pharmacol; 2014 Feb; 274(3):488-93. PubMed ID: 24161345
[TBL] [Abstract][Full Text] [Related]
3. Azure B and a synthetic structural analogue of methylene blue, ethylthioninium chloride, present with antidepressant-like properties.
Delport A; Harvey BH; Petzer A; Petzer JP
Life Sci; 2014 Nov; 117(2):56-66. PubMed ID: 25445435
[TBL] [Abstract][Full Text] [Related]
4. The monoamine oxidase inhibition properties of selected structural analogues of methylene blue.
Delport A; Harvey BH; Petzer A; Petzer JP
Toxicol Appl Pharmacol; 2017 Jun; 325():1-8. PubMed ID: 28377303
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase inhibition by selected dye compounds.
de Beer F; Petzer JP; Petzer A
Chem Biol Drug Des; 2020 Mar; 95(3):355-367. PubMed ID: 31834986
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction.
Ramsay RR; Dunford C; Gillman PK
Br J Pharmacol; 2007 Nov; 152(6):946-51. PubMed ID: 17721552
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibition by selected anilide derivatives.
Legoabe L; Kruger J; Petzer A; Bergh JJ; Petzer JP
Eur J Med Chem; 2011 Oct; 46(10):5162-74. PubMed ID: 21899930
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.
Strydom B; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2010 Feb; 18(3):1018-28. PubMed ID: 20093036
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B.
Yoshida S; Rosen TC; Meyer OG; Sloan MJ; Ye S; Haufe G; Kirk KL
Bioorg Med Chem; 2004 May; 12(10):2645-52. PubMed ID: 15110846
[TBL] [Abstract][Full Text] [Related]
10. Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Nov; 22(21):6632-5. PubMed ID: 23010267
[TBL] [Abstract][Full Text] [Related]
11. The interactions of caffeine with monoamine oxidase.
Petzer A; Pienaar A; Petzer JP
Life Sci; 2013 Aug; 93(7):283-7. PubMed ID: 23850513
[TBL] [Abstract][Full Text] [Related]
12. Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Lourens AC; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Dec; 22(24):7367-70. PubMed ID: 23122857
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors.
Herraiz T; Guillén H
Food Chem Toxicol; 2011 Aug; 49(8):1773-81. PubMed ID: 21554916
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
15. 8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.
Strydom B; Bergh JJ; Petzer JP
Eur J Med Chem; 2011 Aug; 46(8):3474-85. PubMed ID: 21621312
[TBL] [Abstract][Full Text] [Related]
16. Methylene Blue Analogues with Marginal Monoamine Oxidase Inhibition Retain Antidepressant-like Activity.
Delport A; Harvey BH; Petzer A; Petzer JP
ACS Chem Neurosci; 2018 Dec; 9(12):2917-2928. PubMed ID: 29976053
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs.
Chaurasiya ND; Ganesan S; Nanayakkara NP; Dias LR; Walker LA; Tekwani BL
Bioorg Med Chem Lett; 2012 Feb; 22(4):1701-4. PubMed ID: 22264472
[TBL] [Abstract][Full Text] [Related]
18. Role of monoamine oxidase, nitric oxide synthase and regional brain monoamines in the antidepressant-like effects of methylene blue and selected structural analogues.
Harvey BH; Duvenhage I; Viljoen F; Scheepers N; Malan SF; Wegener G; Brink CB; Petzer JP
Biochem Pharmacol; 2010 Nov; 80(10):1580-91. PubMed ID: 20699087
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Santana L; González-Díaz H; Quezada E; Uriarte E; Yáñez M; Viña D; Orallo F
J Med Chem; 2008 Nov; 51(21):6740-51. PubMed ID: 18834112
[TBL] [Abstract][Full Text] [Related]
20. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors.
Herraiz T; Chaparro C
Biochem Biophys Res Commun; 2005 Jan; 326(2):378-86. PubMed ID: 15582589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
